Science Explorer Back to mapMap

Most cited papers from Pyatigorsk Oncology Center

What are the most cited papers from Pyatigorsk Oncology Center?

The most cited paper from Pyatigorsk Oncology Center is "Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study" (Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al., 2011), with 1,110 citations. Next come "A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407" (658) and "Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial" (100).

Showing 50 of 93 papers. Every paper with more than 0 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al. · The Lancet Mar 2011 1,110
2 A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 Luis G Paz-Ares, David Vicente, Ali Reza Tafreshi et al. · Journal of Thoracic Oncology Open access 26 Jun 2020 658
3 Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial Mafalda Oliveira et al. · The Lancet Oncology 29 Oct 2024 100
4 Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study Gunnar Folprecht, Carles Pericay, Mark P. Saunders et al. · Annals of Oncology Open access 18 Apr 2016 85
5 Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer Michael Clemens, Oleg A. Gladkov, Elaina M. Gartner et al. · Breast Cancer Research and Treatment Open access 29 Dec 2014 80
6 Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo et al. · Annals of Oncology Open access Oct 2019 73
7 A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type KRAS who have received first‐line systemic therapy Cathy Eng, Alberto Bessudo, Lowell L. Hart et al. · International Journal of Cancer Open access 18 Feb 2016 72
8 Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY) Stephen B. Hanauer et al. · Gastroenterology Open access 23 May 2024 69
9 PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study Niels Reinmuth, Maciej Bryl, Igor Bondarenko et al. · BioDrugs Open access 23 Jul 2019 63
10 CONNECTION BETWEEN CLINICAL AND RADIOLOGICAL TORQUE OF MEDIALINCISORS AT PHYSIOLOGICAL OCCL Tatyana D. Dmitrienko, Dmitry Domenyuk, Mikhail Porfyriadis et al. · Archiv Euromedica Open access 30 Apr 2019 51
11 DEPENDENCE OF STRESS STRAIN OF DENTAL HARD TISSUES AND PERIODONT ON HORIZONTAL DEFORMATION DEGREE Alexander Lepilin, С. В. Дмитриенко, Dmitry Domenyuk et al. · Archiv Euromedica Open access 30 Apr 2019 41
12 First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers Enriqueta Felip et al. · Cancer Chemotherapy and Pharmacology Open access 17 Mar 2022 26
13 97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407 Andrew George Robinson, David Vicente, Ali Reza Tafreshi et al. · Journal of Thoracic Oncology Open access 27 Mar 2021 25
14 SCANNING ELECTRON MICROSCOPY AND X-RAY SPECTRAL MICROANALYSIS IN STUDYING DENTAL TISSUE RESISTANCE Mikhail Porfyriadis, Dmitry Domenyuk, Anna Arutyunova et al. · Archiv Euromedica Open access 30 Apr 2019 23
15 Pembrolizumab (pembro) + chemotherapy (chemo) in metastatic squamous NSCLC: Final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407 Luiz Paz-Ares, David Vicente, Ali Reza Tafreshi et al. · Annals of Oncology Open access Oct 2019 18
16 DYNAMICS OF PERIODONTAL FIXING CAPACITY THROUGH ORTHODONTIC TREATMENT EMPLOYING EDGEWISE TECHNIQUE Sergey Dmitrienko, Dmitry Domenyuk, Sergey Fischev et al. · Archiv Euromedica Open access 30 Apr 2019 15
17 Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2 Alexey N. Boyko et al. · S S Korsakov Journal of Neurology and Psychiatry 21 Apr 2023 13
18 Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial Tamas Hickish, Ajay Omprakash Mehta, Mei-Ching Liu et al. · Breast Cancer Research and Treatment Open access 9 Feb 2022 13
19 Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study Rubi K. Li, Eriko Tokunaga, Hryhoriy Adamchuk et al. · BioDrugs Open access 2022 13
20 Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS Alexey N. Boyko et al. · S S Korsakov Journal of Neurology and Psychiatry Open access 23 Apr 2024 12
21 Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS Alexey N. Boyko et al. · S S Korsakov Journal of Neurology and Psychiatry 10 Aug 2023 12
22 Analysis of the Caucasus Mineral Waters’ Field’s Modeling Ivan Mitrofanovich Pershin, Alexander V. Martirosyan, Karina V. Martirosyan · Modern Applied Science Open access 29 Dec 2014 10
23 A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer Gabriela Galffy et al. · ESMO Open Open access 2 May 2023 9
24 MANUFACTURING METHODS FOR INDIVIDUAL ALIGNERS AND TRAINERS FROM THERMOPLASTS AND CLINICAL INDICATIONS FOR THEIR APPLICATION С. В. Дмитриенко, Dmitry Domenyuk, Marina Puzdyryova · Archiv Euromedica Open access 30 Apr 2019 9
25 MODERN VIEW ON ANTIBACTERIAL TREATMENT OF A ROOT CHANNEL WITH A BREAK-OFF OF ENDODONTIC TOOL Karen G. Karakov, Karen G. Karakov, Эмилия Хачатурян et al. · The actual problems in dentistry Open access 6 May 2019 9
26 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn’s disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) Jean–Frédéric Colombel et al. · Journal of Crohn s and Colitis Open access 12 Apr 2025 7
27 The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia Tatiana N. Sokolova et al. · Journal of Modern Oncology Open access 19 May 2021 7
28 Influence of connective tissue differentiation on scar tissue formation in children Sergey Viktorovich Minaev, Алина Николаевна Григорова, Oksana V. Vladimirova et al. · Pirogov Russian Journal of Surgery 2021 6
29 2MO Dynamics of ESR1 mutation (ESR1m) circulating tumour DNA (ctDNA) in patients (pts) with estrogen receptor (ER)+ HER2- metastatic breast cancer (mBC) receiving camizestrant or fulvestrant: Exploratory analyses from the SERENA-2 trial Maila Dayane Capuchinho de Oliveira, Erika Paige Hamilton, Yaroslav Kulyaba et al. · ESMO Open Open access May 2024 3
30 Features of the course of childbirth in preeclampsia of varying severity at the present stage I. V. Simanov · RESEARCH RESULTS IN BIOMEDICINE Open access 30 Jun 2020 3
31 Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia В. А. Горбунова et al. · Journal of Modern Oncology Open access 15 Mar 2019 3
32 Synthesis and biological properties of 3-phenoxchromones and 3-phenoxy-4-hydroxy-7-methoxycoumarin Васильев Станислав Александрович, M. S. Luk'yanchikov, G. I. Molchanov et al. · Pharmaceutical Chemistry Journal Jul 1991 3
33 Search algorithms of verbal identity markers in modern scientific discourse Oxana V. Goncharova, Zaur Aslanovich Zavrumov, Svetlana A. Khaleeva · Current Issues in Philology and Pedagogical Linguistics Open access 25 Jun 2024 2
34 English Military Terms Deconstruction in Mass Media Text S.A. Antakli, Oleg Alimuradovich Alimuradov · Current Issues in Philology and Pedagogical Linguistics Open access 25 Jun 2023 2
35 Study of the Level of Overcoming Resistance to Innovative Activities in Members of the Teaching Staff of a General Education Organization Valeria Nikolaevna Orobinskaya, T.N. Mishina, Andrey Petrovich Mazurenko et al. Conference paper 18 Sep 2025 1
36 Assessment of the clinical effectiveness of a specialized fermented milk product for the dietary correction of carbohydrate and fat metabolism disorders Sharafetdinov KhKh, Alla L’vovna Novokshanova, Alla Alekseevna Kochetkova et al. · Voprosy Pitaniya Open access 2024 1
37 The North Caucasus in Russia's geopolitical strategy T. A. Shebzukhova, A. A. Vartumyan, Irina A Vasilyeva · Sovremennaya nauka i innovatsii Open access 2024 1
38 NEUROPROTECTIVE EFFECT OF THEAFLAVINE IN EXPERIMENTAL CHRONIC CEREBROVASCULAR ACCIDENT Dmitry I. Pozdnyakov · Bulletin of Medical Science Open access 2023 1
39 Combined method of renal denervation in an animal model D. I. Bashta, L. I. Vilenskiy, Yu. S. Krivosheev et al. · Patologiya krovoobrashcheniya i kardiokhirurgiya Open access 29 Dec 2022 1
40 Terms of emergence of the main clinical symptoms of preeclampsia at the present stage Симанов, И. В. · Research Result Medicine and Pharmacy Open access 30 Sep 2017 1
41 Germans` Social Awareness In Relation To Russia In The Xvi–Xvii Centuries Elena Malyshkina, Olga Goroshko, Natalya Yuryevna Klimova et al. · ˜The œEuropean Proceedings of Social & Behavioural Sciences Conference paperOpen access 29 Nov 2021 1
42 POTENTIAL OPPORTUNITY OF ANTISENSE THERAPY OF COVID-19 A.N. Goryachev, S.A. Kalantarov, Vadim Tkachev et al. · Современные проблемы науки и образования Open access 2020 1
43 Potential Opportunity of Antisense Therapy of COVID-19 on an in Vitro Model A.N. Goryachev, S.A. Kalantarov, A.G. Severova et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 3 Nov 2020 1
44 SPA TREATMENT OF CHILDREN WITH ENVIRONMENTAL-BURDENED PYELONEPHRITIS ASSOCIATED WITH DISORDERS OF PURINE EXCHANGE Larisa Nikolaevna Shvedunova, Agnessa Sardoevna Kaysinova, Natalia Efimenko et al. · Avicenna Bulletin Open access 2019 1
45 Excesive Scar Formation After Surgical Operations And Injuries: Expirience of Early Diagnosis and Prophyilaxis О В Владимирова, Vladimir Ivanovich Vladimirov, К Р Амлаев et al. · e-Journal of Cardiovascular Medicine Open access 24 Sep 2018 1
46 FARMAKODINAMICESCOE RESEARCH COMPOSITE OF SYRUP FROM VEGETABLE RAW MATERIALS A. M. TEMIRBULATOVA, Eleonora Fedorovna Stepanova, L. P. LEZHNEVA et al. · Кубанский научный медицинский вестник Open access 2017 1
47 Qualitative Distribution of Modes in the Systems with Distributed Parameters Valery V. Grigoriev, Sergey Vladimirovich Bystrov, Olga K. Mansurova et al. · Mekhatronika Avtomatizatsiya Upravlenie Open access Jul 2016 1
48 A Comparative Study of the Pharmacokinetics and Bioaccessibility of Potassium Losartan in Various Medicinal Forms М. В. Гаврилин, С. А. Кулешова · Pharmaceutical Chemistry Journal May 2002 1
49 Privacy in the Legal Regulation of Environmental Information: Balancing Concerns Anna Viktorovna Sidorova, Bela Bertovna Bidova, A. Al. Umarova · Lecture notes in civil engineering Conference paper 2026 0
50 Comparative Analysis of Motion Control Algorithms for a Mobile Robot Tracking a Given Trajectory Danila D. Ampleev, Veronika N. Kuyukova, Karina V. Martirosyan Conference paper 3 Feb 2026 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.